The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
Abstract
BACKGROUND For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered. Multiple biologic therapies and Janus kinase (JAK)inhibitors have been approved since 2014 to treat AD. These guidelines update the 2014 recommendations for management of AD with phototherapy and systemic therapies. OBJECTIVE To provide evidence-based recommendations on the use of phototherapy and systemic therapies for AD in adults. METHODS A multidisciplinary workgroup conducted a systematic review and applied the GRADE approach for assessing the certainty of evidence and formulating and grading recommendations. RESULTS The workgroup developed 11 recommendations on the management of AD in adults with phototherapy and systemic agents, including biologics, oral JAK inhibitors, and other immunomodulatory medications. LIMITATIONS Most randomized controlled trials of phototherapy and systemic therapies for AD are of short duration with subsequent extension studies, limiting comparative long-term efficacy and safety conclusions. CONCLUSIONS We make strong recommendations for the use of dupilumab, tralokinumab, abrocitinib, baricitinib, and upadacitinib. We make conditional recommendations in favor of using phototherapy, azathioprine, cyclosporine, methotrexate, and mycophenolate, and against the use of systemic corticosteroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Self-citationCardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Ytterberg, S. R., Bhatt, D. L., Mikuls, T. R., Koch, G. G., Fleischmann, R., Rivas, J. L., Germino, R., Menon, S., Sun, Y., Wang, C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2109927 · Cited by 1,816
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Blauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261
Guidelines of care for the management of atopic dermatitis
Sidbury, R., Davis, D. M., Cohen, D. E., Cordoro, K. M., Berger, T. G., Bergman, J. N., Chamlin, S. L., Cooper, K. D., Feldman, S. R., Hanifin, J. M., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.030 · Cited by 885
Self-citationWaljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830
Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19574 · Cited by 638
Guttman-Yassky, E., Teixeira, H. D., Simpson, E. L., Papp, K. A., Pangan, A. L., Blauvelt, A., Thaçi, D., Chu, C.-Y., Hong, H. C.-H., Katoh, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00588-2 · Cited by 583
Self-citationThaçi, D., Simpson, E. L., Beck, L. A., Bieber, T., Blauvelt, A., Papp, K., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 572
Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30732-7 · Cited by 522
Blauvelt, A., Teixeira, H. D., Simpson, E. L., Costanzo, A., De Bruin-Weller, M., Barbarot, S., Prajapati, V. H., Lio, P., Hu, X., Wu, T., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.3023 · Cited by 516
de Bruin-Weller, M., Thaçi, D., Smith, C. H., Reich, K., Cork, M. J., Radin, A., Zhang, Q., Akinlade, B., Gadkari, A., Eckert, L., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16156 · Cited by 479
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Bieber, T., Simpson, E. L., Silverberg, J. I., Thaçi, D., Paul, C., Pink, A. E., Kataoka, Y., Chu, C.-Y., DiBonaventura, M., Rojo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2019380 · Cited by 476
Self-citationSowden, J. M., Allen, B. R., Berth-Jones, J., Graham-Brown, R. A. C., Motley, R. J., Finlay, A. Y., Salek, M., Marks, R., Ross, J. S., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Silverberg, J. I., Simpson, E. L., Thyssen, J. P., Gooderham, M., Chan, G., Feeney, C., Biswas, P., Valdez, H., DiBonaventura, M., Nduaka, C., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1406 · Cited by 404
Self-citationReich, K., Teixeira, H. D., de Bruin-Weller, M., Bieber, T., Soong, W., Kabashima, K., Werfel, T., Zeng, J., Huang, X., Hu, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00589-4 · Cited by 402
Self-citationSimpson, E. L., Lacour, J. ‐., Spelman, L., Galimberti, R., Eichenfield, L. F., Bissonnette, R., King, B. A., Thyssen, J. P., Silverberg, J. I., Bieber, T., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.18898 · Cited by 396
Self-citationGuttman-Yassky, E., Thaçi, D., Pangan, A. L., Hong, H. C.-H., Papp, K. A., Reich, K., Beck, L. A., Mohamed, M.-E. F., Othman, A. A., Anderson, J. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.025 · Cited by 369
Self-citationSilverberg, J. I., Toth, D., Bieber, T., Alexis, A. F., Elewski, B. E., Pink, A. E., Hijnen, D., Jensen, T. N., Bang, B., Olsen, C. K., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19573 · Cited by 326
Self-citationGuttman-Yassky, E., Silverberg, J. I., Nemoto, O., Forman, S. B., Wilke, A., Prescilla, R., de la Peña, A., Nunes, F. P., Janes, J., Gamalo, M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.01.018 · Cited by 317
Self-citationSimpson, E. L., Bieber, T., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., & Mastey, V. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.10.043 · Cited by 302
Meggitt, S. J., Gray, J. C., & Reynolds, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68340-2 · Cited by 285
Reich, K., Kabashima, K., Peris, K., Silverberg, J. I., Eichenfield, L. F., Bieber, T., Kaszuba, A., Kolodsick, J., Yang, F. E., Gamalo, M., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.3260 · Cited by 285
Self-citationAzathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial
Berth-Jones, J., Takwale, A., Tan, E., Barclay, G., Agarwal, S., Ahmed, I., Hotchkiss, K., & Graham-Brown, R. A. C. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04989.x · Cited by 262
A randomized trial of methotrexate versus azathioprine for severe atopic eczema
Schram, M. E., Roekevisch, E., Leeflang, M. M. G., Bos, J. D., Schmitt, J., & Spuls, P. I. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.024 · Cited by 260
Reynolds, N. J., Franklin, V., Gray, J. C., Diffey, B. L., & Farr, P. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05114-x · Cited by 252
Reich, K., Thyssen, J. P., Blauvelt, A., Eyerich, K., Soong, W., Rice, Z. P., Hong, H. C.-H., Katoh, N., Valenzuela, F., DiBonaventura, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01199-0 · Cited by 251
Gooderham, M. J., Forman, S. B., Bissonnette, R., Beebe, J. S., Zhang, W., Banfield, C., Zhu, L., Papacharalambous, J., Vincent, M. S., & Peeva, E. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.2855 · Cited by 247
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Guyatt, G. H., Alonso-Coello, P., Schünemann, H. J., Djulbegovic, B., Nothacker, M., Lange, S., Murad, M. H., & Akl, E. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.006 · Cited by 243
Simpson, E. L., Bruin-Weller, M., Flohr, C., Ardern-Jones, M. R., Barbarot, S., Deleuran, M., Bieber, T., Vestergaard, C., Brown, S. J., Cork, M. J., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.06.042 · Cited by 241
Self-citationSALEK, M. S., FINLAY, A. Y., LUSCOMBE, D. K., ALLEN, B. R., BERTH-JONES, J., CAMP, R. D. R., GRAHAM-BROWN, R. A. C., KHAN, G. K., MARKS, R., MOTLEYJ, R. J., et al. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb03170.x · Cited by 217
Drucker, A. M., Eyerich, K., de Bruin-Weller, M. S., Thyssen, J. P., Spuls, P. I., Irvine, A. D., Girolomoni, G., Dhar, S., Flohr, C., Murrell, D. F., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.15928 · Cited by 184
Self-citationCyclosporin in atopic dermatitis: a multicentre placebo-controlled study
JOOST, T., HEULE, F., KORSTANJE, M., BROEK, M. J. T. B., STENVELD, H. J., & VLOTEN, W. A. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb13111.x · Cited by 183
Haeck, I. M., Knol, M. J., ten Berge, O., van Velsen, S. G. A., de Bruin-Weller, M. S., & Bruijnzeel-Koomen, C. A. F. M. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.04.027 · Cited by 177
Drucker, A. M., Morra, D. E., Prieto-Merino, D., Ellis, A. G., Yiu, Z. Z. N., Rochwerg, B., Di Giorgio, S., Arents, B. W. M., Burton, T., Spuls, P. I., et al. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.0455 · Cited by 171
Self-citationDrucker, A. M., Ellis, A. G., Bohdanowicz, M., Mashayekhi, S., Yiu, Z. Z. N., Rochwerg, B., Di Giorgio, S., Arents, B. W. M., Burton, T., Spuls, P. I., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0796 · Cited by 159
Self-citationThe HOME Core outcome set for clinical trials of atopic dermatitis
Williams, H. C., Schmitt, J., Thomas, K. S., Spuls, P. I., Simpson, E. L., Apfelbacher, C. J., Chalmers, J. R., Furue, M., Katoh, N., Gerbens, L. A. A., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.03.017 · Cited by 159
Simpson, E. L., Forman, S. B., Silverberg, J. I., Zirwas, M., Maverakis, E., Han, G., Guttman‐Yassky, E., Marnell, D., Bissonnette, R., Waibel, J. S., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.02.028 · Cited by 142
Self-citationSystemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis
Siegels, D., Heratizadeh, A., Abraham, S., Binnmyr, J., Brockow, K., Irvine, A. D., Halken, S., Mortz, C. G., Flohr, C., Schmid‐Grendelmeier, P., et al. (2020) · Allergy · doi:10.1111/all.14631 · Cited by 137
Schmitt, J. M., Schäkel, K., Fölster‐Holst, R., Bauer, A., Oertel, R., Augustin, M., Aberer, W., Luger, T. A., & Meurer, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09561.x · Cited by 136
Silverberg, J. I., Simpson, E. L., Wollenberg, A., Bissonnette, R., Kabashima, K., DeLozier, A. M., Sun, L., Cardillo, T. E., Nunes, F. P., & Reich, K. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.1273 · Cited by 114
Self-citationPhototherapy for atopic dermatitis
Rodenbeck, D. L., Silverberg, J. I., & Silverberg, N. B. (2016) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2016.05.011 · Cited by 103
Self-citationChen, J. K., Jacob, S. E., Nedorost, S. T., Hanifin, J. M., Simpson, E. L., Boguniewicz, M., Watsky, K. L., Lugo‐Somolinos, A., Hamann, C. R., Eberting, C. L. D., et al. (2016) · Dermatitis · doi:10.1097/der.0000000000000208 · Cited by 103
Self-citationCzech, W., Bräutigam, M., Weidinger, G., & Schöpf, E. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103815 · Cited by 96
Goujon, C., Viguier, M. A., Staumont-Sallé, D., Bernier, C., Guillet, G., Lahfa, M., le Bouëdec, M.-C. F., Cambazard, F., Bottigioli, D., Grande, S., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.07.007 · Cited by 95
Changes in Lesional and Non-lesional Skin Microbiome During Treatment of Atopic Dermatitis
Kwon, S., Choi, J., Shin, J. W., Huh, C., Park, K., Du, M., Yoon, S., & Na, J. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-3089 · Cited by 90
Bieber, T. R. M., Reich, K., Paul, C. F., Tsunemi, Y., Augustin, M., Lacour, J. ‐., Ghislain, P., Dutronc, Y., Liao, R., Yang, F. E., et al. (2022) · British Journal of Dermatology · doi:10.1111/bjd.21630 · Cited by 89
Granlund, H., Erkko, P., Remitz, A., Langeland, T., Helsing, P., Nuutinen, M., & Reitamo, S. (2001) · Acta Dermato Venereologica · doi:10.1080/000155501750208137 · Cited by 79
Zhao, Y. P., Wu, L., Lu, Q., Gao, X., Zhu, X., Yao, X., Li, L., Li, W., Ding, Y., Song, Z., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20690 · Cited by 77
Cutaneous T‐cell lymphoma following dupilumab use: a systematic review
Park, A., Wong, L., Lang, A., Kraus, C. N., Anderson, N., & Elsensohn, A. N. (2022) · International Journal of Dermatology · doi:10.1111/ijd.16388 · Cited by 71
Pacor, M. L., Lorenzo, G. D., Martinelli, N., Mansueto, P., Rini, G. B., & Corrocher, R. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1907.x · Cited by 70
Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
Phan, K. H., & Smith, S. D. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1642996 · Cited by 53
Grinich, E. E., Schmitt, J. M., Küster, D., Spuls, P. I., Williams, H. C., Chalmers, J. R., Thomas, K. S., Apfelbacher, C., Prinsen, C. A. C., Furue, M., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16732 · Cited by 47
Lam, M., Zhu, J. W., Maqbool, T., Adam, G. P., Tadrous, M., Rochon, P. A., & Drucker, A. M. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.2940 · Cited by 47
Self-citationMerola, J. F., Bagel, J., Almgren, P., Røpke, M. A., Lophaven, K. W., Vest, N. S., & Grewal, P. S. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.03.032 · Cited by 47
Drucker, A. M., Lam, M., Flohr, C., Thyssen, J. P., Kabashima, K., Bissonnette, R., Dlova, N. C., Aoki, V., Chen, M., Yu, J., et al. (2022) · Dermatitis · doi:10.1097/der.0000000000000845 · Cited by 34
Self-citationPhototherapy for atopic eczema
Musters, A. H., Mashayekhi, S., Flohr, C., Drucker, A. M., Gerbens, L., Ferguson, J., Ibbotson, S., Dawe, R. S., Garritsen, F., Brouwer, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013870 · Cited by 31
Self-citationTzung, T., Lin, C., Chen, Y., & Yang, C. (2005) · Acta Dermato Venereologica · doi:10.1080/00015550510044163 · Cited by 26
Skin Cancer after PUVA Treatment for Psoriasis
Morgan, R. W. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909063011014 · Cited by 21
Leukotriene receptor antagonists for eczema
Ferguson, L., Futamura, M., Vakirlis, E., Kojima, R., Sasaki, H., Roberts, A., & Mori, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011224.pub2 · Cited by 18
Youssef, R., Hafez, V. G., Elkholy, Y. S., & Mourad, A. I. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1708246 · Cited by 18
Cited by
Guttman-Yassky, E., Renert-Yuval, Y., & Brunner, P. M. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02519-4 · Cited by 321
Metadata
- Authors
- Davis, D. M. R., Drucker, A. M., Alikhan, A., Bercovitch, L., Cohen, D. E., Darr, J. M., Eichenfield, L. F., Frazer-Green, L., Paller, A. S., Schwarzenberger, K., Silverberg, J. I., Singh, A. M., Wu, P. A., & Sidbury, R.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2024-02
- Volume
- 90
- Issue
- 2
- Pages
- e43-e56
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W4388454963
- Cited by
- 265
- References
- 62
- FWCI
- 60.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.